TNF Pharmaceuticals (TNFA) Competitors $0.36 +0.00 (+0.85%) Closing price 03:42 PM EasternExtended Trading$0.36 +0.01 (+1.40%) As of 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsSEC FilingsTrendsBuy This Stock TNFA vs. SONN, VRAX, ALLR, CDT, IMCC, RDHL, APVO, SPRC, SNPX, and PPBTShould you be buying TNF Pharmaceuticals stock or one of its competitors? The main competitors of TNF Pharmaceuticals include Sonnet BioTherapeutics (SONN), Virax Biolabs Group (VRAX), Allarity Therapeutics (ALLR), Conduit Pharmaceuticals (CDT), IM Cannabis (IMCC), RedHill Biopharma (RDHL), Aptevo Therapeutics (APVO), SciSparc (SPRC), Synaptogenix (SNPX), and Purple Biotech (PPBT). These companies are all part of the "pharmaceutical products" industry. TNF Pharmaceuticals vs. Sonnet BioTherapeutics Virax Biolabs Group Allarity Therapeutics Conduit Pharmaceuticals IM Cannabis RedHill Biopharma Aptevo Therapeutics SciSparc Synaptogenix Purple Biotech TNF Pharmaceuticals (NASDAQ:TNFA) and Sonnet BioTherapeutics (NASDAQ:SONN) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, community ranking, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and dividends. Which has more risk and volatility, TNFA or SONN? TNF Pharmaceuticals has a beta of 2.32, suggesting that its stock price is 132% more volatile than the S&P 500. Comparatively, Sonnet BioTherapeutics has a beta of 0.39, suggesting that its stock price is 61% less volatile than the S&P 500. Does the MarketBeat Community prefer TNFA or SONN? Sonnet BioTherapeutics received 20 more outperform votes than TNF Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformTNF PharmaceuticalsN/AN/ASonnet BioTherapeuticsOutperform Votes2083.33% Underperform Votes416.67% Is TNFA or SONN more profitable? TNF Pharmaceuticals' return on equity of -180.71% beat Sonnet BioTherapeutics' return on equity.Company Net Margins Return on Equity Return on Assets TNF PharmaceuticalsN/A -180.71% -84.27% Sonnet BioTherapeutics N/A -408.93%-174.13% Do insiders and institutionals hold more shares of TNFA or SONN? 9.6% of TNF Pharmaceuticals shares are owned by institutional investors. Comparatively, 9.4% of Sonnet BioTherapeutics shares are owned by institutional investors. 1.2% of TNF Pharmaceuticals shares are owned by insiders. Comparatively, 2.0% of Sonnet BioTherapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media prefer TNFA or SONN? In the previous week, Sonnet BioTherapeutics had 2 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 4 mentions for Sonnet BioTherapeutics and 2 mentions for TNF Pharmaceuticals. TNF Pharmaceuticals' average media sentiment score of 0.62 beat Sonnet BioTherapeutics' score of -0.33 indicating that TNF Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TNF Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sonnet BioTherapeutics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer TNFA or SONN? Sonnet BioTherapeutics has a consensus target price of $20.00, indicating a potential upside of 1,370.59%. Given Sonnet BioTherapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Sonnet BioTherapeutics is more favorable than TNF Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TNF Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Sonnet BioTherapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better earnings & valuation, TNFA or SONN? TNF Pharmaceuticals has higher earnings, but lower revenue than Sonnet BioTherapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTNF PharmaceuticalsN/AN/A-$4MN/AN/ASonnet BioTherapeutics$1M4.17-$7.44MN/AN/A SummarySonnet BioTherapeutics beats TNF Pharmaceuticals on 7 of the 13 factors compared between the two stocks. Remove Ads Get TNF Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNFA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNFA vs. The Competition Export to ExcelMetricTNF PharmaceuticalsDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$984,000.00$2.46B$5.68B$8.32BDividend YieldN/A0.70%4.55%4.02%P/E RatioN/A5.5724.5519.25Price / SalesN/A52.02395.7294.09Price / CashN/A15.7538.1634.64Price / Book0.053.067.064.46Net Income-$4M-$65.73M$3.19B$247.07M7 Day Performance-8.23%-1.63%1.49%3.05%1 Month Performance-23.04%-7.49%5.87%-2.85%1 Year PerformanceN/A-17.20%14.94%4.63% TNF Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNFATNF PharmaceuticalsN/A$0.36+0.8%N/AN/A$984,000.00N/A0.006Gap UpSONNSonnet BioTherapeutics1.3844 of 5 stars$1.39+1.8%$20.00+1,338.8%-34.6%$4.26M$1M0.0010VRAXVirax Biolabs Group0.2477 of 5 stars$1.28-6.6%N/A+64.1%$4.14M$84,872.000.005ALLRAllarity Therapeutics0.2166 of 5 stars$0.93-3.2%N/A-99.5%$4.12MN/A0.0010Upcoming EarningsCDTConduit PharmaceuticalsN/A$1.11+1.8%N/A-99.7%$4.04MN/A0.003Positive NewsIMCCIM Cannabis0.3496 of 5 stars$1.79+0.3%N/A-30.1%$3.99M$51.39M-0.52340Upcoming EarningsGap DownRDHLRedHill Biopharma0.2358 of 5 stars$3.01+17.6%N/A-99.0%$3.86M$3.71M0.00210APVOAptevo Therapeutics2.4685 of 5 stars$2.64+9.5%$10,952.00+414,748.5%-100.0%$3.85M$3.11M0.0050Gap DownSPRCSciSparc0.4641 of 5 stars$0.37-1.1%N/A-83.8%$3.84M$1.75M0.004Gap DownSNPXSynaptogenix2.0068 of 5 stars$2.80+2.9%$14.00+400.0%-45.1%$3.80MN/A0.004Gap UpPPBTPurple Biotech2.0127 of 5 stars$2.80+2.6%$33.00+1,078.6%N/A$3.73MN/A-0.3220Gap Up Remove Ads Related Companies and Tools Related Companies Sonnet BioTherapeutics Alternatives Virax Biolabs Group Alternatives Allarity Therapeutics Alternatives Conduit Pharmaceuticals Alternatives IM Cannabis Alternatives RedHill Biopharma Alternatives Aptevo Therapeutics Alternatives SciSparc Alternatives Synaptogenix Alternatives Purple Biotech Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TNFA) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TNF Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TNF Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TNFA Stock Free TNFA Stock Alerts